Early recovery after sublobar resection versus lobectomy tracked with wearable devices
A Prospective Observational Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy
The First Affiliated Hospital of Guangzhou Medical University · NCT07288710
This project tests whether a multimodal digital wearable can track early subjective and objective recovery in adults with lung cancer having sublobar resection or lobectomy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The First Affiliated Hospital of Guangzhou Medical University (other) |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT07288710 on ClinicalTrials.gov |
What this trial studies
This single-center, prospective observational study enrolled adults scheduled for video-assisted thoracoscopic surgery (VATS) between March and December 2023 and used a multimodal digital device to collect subjective and objective recovery data. Patients meeting ASA grade III or below and without lymph node or distant metastasis were followed through hospitalization with wearable and smartphone-based measures. The study compared recovery patterns between those undergoing sublobar resection and those undergoing lobectomy, focusing on early postoperative outcomes. Participation required the ability to use a smartphone and comply with wearable-device data collection.
Who should consider this trial
Good fit: Ideal candidates are adults with resectable lung cancer scheduled for VATS sublobar resection or lobectomy who are ASA grade III or lower and can use a smartphone and wearable device.
Not a fit: Patients without a smartphone, unable to use wearable devices, with incomplete device data during hospitalization, or with lymph node or distant metastasis are unlikely to benefit from this protocol.
Why it matters
Potential benefit: If successful, this approach could give clinicians and patients clearer, objective information about early recovery to guide postoperative care and rehabilitation.
How similar studies have performed: Wearable-based monitoring has shown promise for tracking recovery after other surgeries, but direct, digital comparisons of sublobar resection versus lobectomy in lung cancer remain limited, making this approach partly novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. adult patients (age ≥ 18 years) 2. American Society of Anesthesiologists (ASA) grade of III or below 3. scheduled for VATS from March to December 2023 Exclusion Criteria: 1. age \<18 years 2. inability or poor compliance to use wearable devices 3. lack of smartphone 4. incomplete digital device data during hospitalization 5. patients with lymph node or distant metastasis
Where this trial is running
Guangzhou, Guangdong
- Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University — Guangzhou, Guangdong, China (RECRUITING)
Study contacts
- Study coordinator: Jianxing He, M.D.
- Email: drjianxing.he@gmail.com
- Phone: +86-20-83337792
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lung Cancer, Lobectomy, Sublobar Resection